|
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma |
|
|
|
Title: |
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma |
Author: |
Propper, D. Davidenko, I. Bridgewater, J. Kupcinskas, L. Fittipaldo, A. Hillenbach, C. Klughammer, B. Ducreux, M. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 25 () nr. 7 pages 1384-1390 |
Year: |
2014 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|